Hypoxia and high glucose cause exaggerated mesangial cell growth and collagen synthesis: role of osteopontin.

The effect of hypoxia on the proliferation and collagen synthesis of cultured rat mesangial cells was examined under normal-glucose (NG, 5 mM) and high-glucose (HG, 25 mM)-media conditions. In addition, a role for osteopontin (OPN) in mediating these processes was assessed. Quiescent cultures were exposed to hypoxia (3% O(2)) and normoxia (18% O(2)) in a serum-free medium with NG or HG, and cell proliferation, collagen synthesis, and OPN expression were assessed. Cells exposed to hypoxia in NG medium resulted in significant increases in [(3)H]thymidine incorporation, cell number, and [(3)H]proline incorporation, respectively. HG incubations also produced significant stimulation of these parameters under normoxic conditions, which were markedly enhanced in cells exposed to hypoxia in HG medium. In addition, hypoxia and HG stimulated the mRNA levels of type IV collagen, and the combination of hypoxia and HG resulted in additive increases in type IV collagen expression. Hypoxia and HG also stimulated OPN mRNA and protein levels in an additive fashion. A neutralizing antibody to OPN or its beta(3)-integrin receptor significantly blocked the effect of hypoxia and HG on proliferation and collagen synthesis. In conclusion, these results demonstrate for the first time that hypoxia in HG medium produces exaggerated mesangial cell growth and type IV collagen synthesis. In addition, OPN appears to play a role in mediating the accelerated mesangial cell growth and collagen synthesis found in a hyperglycemic and hypoxic environment.

[1]  C. Alpers,et al.  Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. , 1994, Kidney international.

[2]  R. Tannen,et al.  Chronic hypoxia induces proliferation of cultured mesangial cells: role of calcium and protein kinase C. , 1997, American journal of physiology. Renal physiology.

[3]  R. Natarajan,et al.  Vascular smooth muscle cells exhibit increased growth in response to elevated glucose. , 1992, Biochemical and biophysical research communications.

[4]  A Fournier,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1994, The New England journal of medicine.

[5]  D. Rogers,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus , 1994 .

[6]  S. Schwartz,et al.  Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[7]  W. Couser,et al.  Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. , 1993, Kidney international.

[8]  E. Engvall,et al.  Integrins and vascular extracellular matrix assembly. , 1997, The Journal of clinical investigation.

[9]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.

[10]  L. Fine,et al.  Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia. , 2000, Kidney international. Supplement.

[11]  R. Atkins,et al.  IL-1 up-regulates osteopontin expression in experimental crescentic glomerulonephritis in the rat. , 1999, The American journal of pathology.

[12]  T. Candresse,et al.  Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[13]  B. J. Peters.  The kidney in diabetes. , 1958, Journal - Michigan State Medical Society.

[14]  P. Chang,et al.  Osteopontin stimulates a subpopulation of quiescent human prostate epithelial cells with high proliferative potential to divide in vitro , 1998, The Prostate.

[15]  S. Santilli,et al.  Alloxan diabetes alters the rabbit transarterial wall oxygen gradient. , 1993, Journal of vascular surgery.

[16]  L. Akyürek,et al.  Ischemia causes rapidly progressive nephropathy in the diabetic rat. , 1997, Kidney international.

[17]  J. Norman,et al.  Hypoxia stimulates proximal tubular cell matrix production via a TGF-beta1-independent mechanism. , 1997, Kidney international.

[18]  J. Kreisberg,et al.  High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. , 1990, The American journal of pathology.

[19]  C. Alpers,et al.  Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor , 1992, The Journal of experimental medicine.

[20]  R. Larkins,et al.  Effect of Prostaglandin E2 and Hyaluronan on Mesangial Cell Proliferation: A Potential Contribution to Glomerular Hypercellularity in Diabetes , 1996, Diabetes.

[21]  C. Alpers,et al.  Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. , 1992, Kidney international.

[22]  R. Linsenmeier,et al.  Retinal hypoxia in long-term diabetic cats. , 1998, Investigative ophthalmology & visual science.

[23]  D. Batlle,et al.  Osteopontin mediates hypoxia-induced proliferation of cultured mesangial cells: role of PKC and p38 MAPK. , 2000, Kidney international.

[24]  S. Klahr,et al.  Osteopontin Expression in the Kidney during Unilateral Ureteral Obstruction , 1998, Mineral and Electrolyte Metabolism.

[25]  G. King,et al.  Protein kinase C activation and the development of diabetic complications. , 1998, Diabetes.

[26]  K. Sharma,et al.  High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β , 1992 .

[27]  W. Couser,et al.  Does extracellular matrix expansion in glomerular disease require mesangial cell proliferation? , 1994, Kidney international. Supplement.

[28]  W. Hung,et al.  Interaction between high glucose and TGF-beta in cell cycle protein regulations in MDCK cells. , 1998, Journal of the American Society of Nephrology : JASN.

[29]  R. Tannen,et al.  Mechanisms of chronic hypoxia-induced renal cell growth. , 1999, Kidney International.

[30]  G. Wolf,et al.  Molecular mechanisms of diabetic renal hypertrophy. , 1999, Kidney international.

[31]  C. Alpers,et al.  Cellular events in the evolution of experimental diabetic nephropathy. , 1995, Kidney international.

[32]  A. Peri,et al.  Potential roles of osteopontin and αVβ3 integrin in the development of coronary artery restenosis after angioplasty , 1997 .

[33]  C. Tschöpe,et al.  Upregulation of osteopontin expression in renal cortex of streptozotocin-induced diabetic rats is mediated by bradykinin. , 1998, Diabetes.

[34]  C. Alpers,et al.  Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. , 1993, The Journal of clinical investigation.

[35]  G. Gillespie,et al.  TPA-mediated regulation of osteopontin in human malignant glioma cells. , 1998, Anticancer research.

[36]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[37]  M. Cotter,et al.  Metabolic and Vascular Factors in the Pathogenesis of Diabetic Neuropathy , 1997, Diabetes.

[38]  K. Yokote,et al.  Enhanced expression of osteopontin by high glucose in cultured rat aortic smooth muscle cells. , 1999, Biochemical and Biophysical Research Communications - BBRC.

[39]  H. Sasamura,et al.  Vascular endothelial growth factor activates MAP kinase and enhances collagen synthesis in human mesangial cells. , 1999, Kidney international.